` SCIB (SciBase Holding AB (publ)) vs OMX Stockholm 30 Comparison - Alpha Spread

S
SCIB
vs
O
OMX Stockholm 30

Over the past 12 months, SCIB has underperformed OMX Stockholm 30, delivering a return of -14% compared to the OMX Stockholm 30's +15% growth.

Stocks Performance
SCIB vs OMX Stockholm 30

Loading
SCIB
OMX Stockholm 30
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
SCIB vs OMX Stockholm 30

Loading
SCIB
OMX Stockholm 30
Difference
www.alphaspread.com

Performance By Year
SCIB vs OMX Stockholm 30

Loading
SCIB
OMX Stockholm 30
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
SciBase Holding AB (publ) vs Peers

OMX Stockholm 30
SCIB
ABT
ISRG
BSX
SYK
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

SciBase Holding AB (publ)
Glance View

Market Cap
149.1m SEK
Industry
Health Care

SciBase Holding AB is a global medical technology company, which engages in the development and sale of instruments for the detection of skin cancer and other skin diseases. The company is headquartered in Sundbyberg, Stockholm and currently employs 23 full-time employees. The company went IPO on 2015-06-02. The firm specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma. Nevisense analyze suspicious lesions by using Electrical Impedance Spectroscopy (EIS) which is applied as an electrical signal to the skin. The diagnostic product is sold in Nordic countries, Belgium, Germany, Great Britain and Australia.

SCIB Intrinsic Value
1.72 SEK
Undervaluation 79%
Intrinsic Value
Price
S
Back to Top